Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update

Legend Biotech (LEGN) Tops Q4 EPS by 6c, Revenues Beat

March 18, 2021 7:05 AM EDT

Legend Biotech (NASDAQ: LEGN) reported Q4 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $40.78 million versus the consensus estimate of $13 million.

This was a defining year for Legend Biotech, as we achieved important pipeline advancements and... More